Bowel Cancer Australia funds research that has the potential to improve survival and/or help build a path toward a cure and integrates published research into our awareness, advocacy, and support strategies.

Lawrence Penn Chair
Dedicated to leading edge bowel cancer discoveries In May 2018, researching a cure for Australia’s second deadliest cancer is to receive a major boost with…
Learn More
Bowel cancer research group
The Bowel Cancer and Biomarker Research Group has a focus on translational cancer research working at the interface of science and clinical research. The Group…
Learn More
Early-onset bowel cancer research
Bowel Cancer Australia has announced a team led by Professor Michael Samuel as the successful applicant for a three-year $600k early-onset bowel cancer research project…
Learn More
Symposium
In November 2024, Bowel Cancer Australia in collaboration with A/Prof Daniel Buchanan, Head of the Colorectal Oncogenomics Group, Department of Clinical Pathology and Centre for…
Learn More
Patient-reported measures
What are patient-reported measures? Patient Reported Measures (PRMs) are questionnaires that capture a patient’s perspective of their health, healthcare experiences and the impact disease and…
Learn More
Clinical trials
What is a clinical trial? Clinical trials are carefully controlled research studies designed to look at very specific aspects of a single treatment, or to…
Learn More

Early-Onset Bowel Cancer Research

ROCK, Rho-associated kinase, is an enzyme (protein) found in all of us, that controls the shape and movement of cells within the body. ROCK goes into overdrive in people with bowel cancer, accelerating the growth and spread of the disease.